We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-3.74%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$309B
AUM Growth
-$29.4B
Cap. Flow
-$6.3B
Cap. Flow %
-2.04%
Top 10 Hldgs %
22.53%
Holding
3,477
New
138
Increased
1,588
Reduced
1,481
Closed
89

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$712M
2
META icon
Meta Platforms (Facebook)
META
+$565M
3
PYPL icon
PayPal
PYPL
+$556M
4
MS icon
Morgan Stanley
MS
+$541M
5
PFE icon
Pfizer
PFE
+$388M

Sector Composition

Rank Sector Weight
1 Technology 24.81%
2 Financials 12.45%
3 Healthcare 12.44%
4 Consumer Discretionary 11.85%
5 Industrials 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTAI icon
2801
BioXcel Therapeutics
BTAI
$27.8M
$958K ﹤0.01%
3,563
-201
-5% -$58.3K
MAX icon
2802
MediaAlpha
MAX
$821M
$956K ﹤0.01%
64,145
+810
+1% +$11.3K
IMGO
2803
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$954K ﹤0.01%
53,053
+39,318
+286% +$816K
AMSC icon
2804
American Superconductor
AMSC
$1.59B
$950K ﹤0.01%
108,469
+616
+0.6% +$5.27K
NBP
2805
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$942K ﹤0.01%
58,000
-14,600
-20% -$374K
TK icon
2806
Teekay
TK
$985M
$941K ﹤0.01%
284,345
+62,993
+28% +$204K
VIEW
2807
DELISTED
View, Inc. Class A Common Stock
VIEW
$940K ﹤0.01%
7,124
-149
-2% -$22.5K
ENDP
2808
DELISTED
Endo International plc
ENDP
$935K ﹤0.01%
399,766
CTRN icon
2809
Citi Trends
CTRN
$605M
$933K ﹤0.01%
26,056
-2,032
-7% -$95K
SB icon
2810
Safe Bulkers
SB
$774M
$931K ﹤0.01%
204,706
-7,558
-4% -$30.8K
BVS icon
2811
Bioventus
BVS
$1.19B
$928K ﹤0.01%
67,586
+1,935
+3% +$25.9K
ITRN icon
2812
Ituran Location and Control
ITRN
$1.05B
$928K ﹤0.01%
40,302
KNTE
2813
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$925K ﹤0.01%
91,945
+2,069
+2% +$22.8K
CBAY
2814
DELISTED
Cymabay Therapeutics
CBAY
$924K ﹤0.01%
287,914
+5,245
+2% +$16.5K
INFU icon
2815
InfuSystem Holdings
INFU
$249M
$921K ﹤0.01%
83,744
+879
+1% +$11.3K
DADA
2816
DELISTED
Dada Nexus
DADA
$911K ﹤0.01%
99,800
-17,518
-15% -$171K
FRBK
2817
DELISTED
Republic First Bancorp Inc
FRBK
$909K ﹤0.01%
172,748
+20,542
+13% +$98.8K
AVNW icon
2818
Aviat Networks
AVNW
$273M
$903K ﹤0.01%
31,215
-541
-2% -$15.8K
SFT
2819
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$902K ﹤0.01%
33,661
-9,541
-22% -$212K
ITIC
2820
Investors Title Co
ITIC
$547M
$898K ﹤0.01%
4,405
-94
-2% -$18.7K
BHR
2821
Braemar Hotels & Resorts
BHR
$142M
$897K ﹤0.01%
152,746
+2,187
+1% +$12.5K
NWPX icon
2822
NWPX Infrastructure Inc
NWPX
$1.15B
$894K ﹤0.01%
33,947
-851
-2% -$24.5K
CGNT icon
2823
Cognyte Software
CGNT
$680M
$888K ﹤0.01%
78,481
CRMD icon
2824
CorMedix
CRMD
$584M
$880K ﹤0.01%
177,925
+1,329
+0.8% +$6.08K
ATCX
2825
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$880K ﹤0.01%
71,429
-71,197
-50% -$742K

Similar funds

Nuveen's Q1 2022 Portfolio in Review

As of Q1 2022, Nuveen held 3,477 positions worth $309B, down 8.7% from $338B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q1 2022 filing shows 138 new, 1,588 increased, 1,481 reduced and 89 closed positions. Its largest new stake was Constellation Energy: 1,208,173 shares worth $59.5M. The largest sale was Qualcomm, an estimated $712M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q1 2022 buy was Constellation Energy: 1,208,173 shares worth $59.5M.
  • Nuveen added most to Advanced Micro Devices in Q1 2022, an estimated $949M increase.
  • Nuveen's biggest Q1 2022 reduction was Qualcomm, cutting an estimated $712M.
  • Nuveen fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $264M.
  • Nuveen's ten largest holdings make up 23% of its $309B portfolio in Q1 2022.
  • Nuveen opened 138 new positions and closed 89 in Q1 2022.
  • Nuveen's portfolio value fell 8.7% quarter-over-quarter to $309B.

Based on Nuveen's 13F filing for Q1 2022, filed 16 May 2022.